Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001140361-25-016323
Filing Date
2025-04-29
Accepted
2025-04-29 16:10:43
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-04-29

Document Format Files

Seq Description Document Type Size
1 ARS ny20042825x3_ars.pdf ARS 719461
  Complete submission text file 0001140361-25-016323.txt   992473
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics, Inc. (Filer) CIK: 0001650648 (see all company filings)

EIN.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-39782 | Film No.: 25887654
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)